about
Ibrutinib in mantle cell lymphoma patients: glass half full? Evidence and opinionImpact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single centerContinued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736.Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cellsWhat Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.Brentuximab: is it time for a new "B" in ABVD?MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk.Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinibHow I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemiaFive-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphomaVenetoclax and obinutuzumab for frontline treatment of chronic lymphocytic leukemia
P50
Q26783430-DFDCB3B1-2E9B-4228-9AF4-9DFEFA968730Q33717615-AF7B6DE5-4B95-41AC-87B6-6BA84CA56BFBQ36068667-4EECA483-65FE-4D99-B97C-A8E35998D678Q36888218-CFE85F3E-6197-4FD8-B107-B0D6AE338574Q37022297-621145B8-95E3-43B6-A71D-3B8415761F33Q39154057-1BA3ADFF-DF1B-49AE-806B-BF57D6526B11Q40216708-9BDEF883-36FA-4D49-A07F-83C7C000AD37Q48344099-03BA2A9E-8B35-48ED-903D-25F7E5D4970DQ50175260-F09C6F30-E839-4A05-A387-820C993AD856Q64055227-E903F5AF-BF85-40B3-A396-2FFAF64F2EBBQ91044330-75498D40-AB5A-4156-B158-F70DFFA55432Q92090070-0D3CA994-A8FF-402D-9DCF-D44AD570B2F9Q93130659-FD065B87-E6D0-44A6-B3E4-4442E29E58F5
P50
description
researcher, ORCID id # 0000-0001-9188-5008
@en
wetenschapper
@nl
name
Deborah M Stephens
@ast
Deborah M Stephens
@en
Deborah M Stephens
@es
Deborah M Stephens
@nl
type
label
Deborah M Stephens
@ast
Deborah M Stephens
@en
Deborah M Stephens
@es
Deborah M Stephens
@nl
prefLabel
Deborah M Stephens
@ast
Deborah M Stephens
@en
Deborah M Stephens
@es
Deborah M Stephens
@nl
P106
P1153
16167897500
57190667390
P31
P496
0000-0001-9188-5008